Request a Pilot
Pilot access

Explore a BactoAI pilot.

BactoAI is a research prototype, not approved for clinical use.

Research Access

For academic and public-health partners.

  • Pilot pricing for LMICs
  • Research and surveillance collaboration
  • 3 antibiotics currently modeled, with more planned
Request a Pilot

Pilot

Seeking sites for planned independent validation; no clinical validation has been done yet.

  • Supervised evaluation on local isolates
  • Conventional laboratory confirmation
  • Joint review of pilot outcomes
Request a Pilot

Partnership

Co-development and data collaboration.

  • Collaborative model development
  • Genomic data collaboration by agreement
  • Shared research and validation goals
Request a Pilot

Current modeled scope: Meropenem, Ciprofloxacin, and Cefotaxime.

FAQ

Frequently asked questions

BactoAI is a research prototype that predicts antimicrobial resistance from assembled genomes in FASTA. It supports phenotypic susceptibility testing and does not replace it. Not approved for clinical use.